COVID-19 inoculations, long-term safety and efficacy

ASE made this Official Information request to Ministry of Health

Response to this request is delayed. By law, Ministry of Health should normally have responded promptly and by (details and exceptions)

From: ASE

Dear Ministry of Health,

This request extends to all persons, boards, councils, committees, subcommittees, organisations, bodies, or individuals advising on such matters, or otherwise exerting influence in any capacity. If this request relates to information that you have reason to believe may be held by any other persons or bodies, I trust that you will advise accordingly.

For products being marketed as "vaccines", what time period does The Ministry of Health consider the minimum period of time for safety and efficacy data to be considered "long-term data"? For products being marketed as "vaccines", what time period does The Ministry of Health consider a typical period of time for safety and efficacy data to be considered "long-term data"? What is the scientific and medical basis of this determination?

Does The Ministry of Health posses any long-term safety data for any COVID-19 inoculation? If so, what is that data?

Does The Ministry of Health posses any long-term efficacy data for any COVID-19 inoculation? If so, what is that data?

Have the manufacturers of any COVID-19 inoculation, directly or indirectly, provided to The Ministry of Health any claims or evidence of long-term safety and/or efficacy? If so, what claims or evidence have been provided?

Have the manufacturers of any COVID-19 inoculation, directly or indirectly, provided to The Ministry of Health any disclaimers of long-term safety and/or efficacy? If so, what disclaimers have been provided?

In the absence of long-term safety and efficacy data, on what basis can these products/treatments be claimed to be "safe" and "effective"? If such claims as "safe" and "effective" are implicitly inclusive of long-term safety and efficacy data, what long-term data substantiates such claims? If such claims as "safe" and "effective" exclude long-term claims of safety and efficacy, how is that exclusion effectively being communicated to policy-makers, media, healthcare providers, the general public, and other parties?

In the absence of long-term safety and efficacy data, is it reasonable or unreasonable to consider these products/treatments "experimental"? On what scientific and medical basis would such a definition be determined? If The Ministry of Health has not considered this, please explain why.

Regardless of terminology, how does such absence of long-term safety and efficacy data affect healthcare providers' legal and ethical obligations to facilitate informed consent? How does this affect healthcare providers' legal and ethical obligations to empower their patients to exercise their rights of informed consent? How does this affect patients' rights regarding informed consent? If The Ministry of Health has not considered this, please explain why.

What information does The Ministry of Health posses in relation to the use of zinc sulfate and/or inhalation chambers, used in New Zealand during the 1918 Influenza Pandemic?

What lessons has The Ministry of Health learned, subsequent to that use of zinc sulfate and inhalation chambers, and their mandated uses during the 1918 Influenza Pandemic? How can the public be assured that gross errors of public health policy, public health mandates, pandemic response, and rushed treatments are not being repeated? If The Ministry of Health has not considered this, please explain why.

In the absence of long-term safety and efficacy data, how can it ever be possible to determine that a pharmaceutical treatment is "safe" and "effective"? In the absence of long-term safety and efficacy data, can it ever be possible to determine that a pharmaceutical treatment is "safe" and "effective"? If The Ministry of Health has not considered this, please explain why.

• 〃During the 1918 flu pandemic in New Zealand, inhalation chambers were set up in towns and cities as ameans to boost immunity. The public were encouraged to attend these chambers and inhale a zinc sulfate mist, a process that was said to disinfect the lungs and throat and protect against infection. In reality, the inhalation of zinc sulfate caused damage to the lungs and throat, thereby making participants more susceptible to infection. ¶ In towns such as Ashburton, New Zealand for example, in order to be eligible to travel by train, people had to present documentation at the train station proving that they had been through the inhalation chamber.〃 - https://en.wikipedia.org/wiki/Zinc_sulfa...(medical_use)#Misuse

• ASHBURTON GUARDIAN, VOLUME XXXIX, ISSUE 9451, 14 NOVEMBER 1918, PAGE 4 - https://paperspast.natlib.govt.nz/newspa...

• INHALATION - Vapour chambers - https://www.nzgeo.com/stories/inhalation/

• Inhalation chamber during the 1918 influenza pandemic - https://nzhistory.govt.nz/media/sound/in...

Thank you,
ASE

Link to this

From: OIA Requests

Kia ora,

 

Thank you for your Official Information Act (the Act) request. This is
an automatic reply to let you know we received it.

 

Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. We
will endeavour to acknowledge your request as soon as possible. Further
information about COVID-19 can be found on our
website: [1]https://www.health.govt.nz/our-work/dise...

 

In accordance with the Act, we'll let you know our decision within no more
than 20 working days. If you'd like to calculate the timeframe, you can
use the Ombudsman's online calculator
here: [2]http://www.ombudsman.parliament.nz/

If you have any questions while we're processing your request, please let
us know via [3][email address]

 

Ngā mihi  

OIA Services Team  

   

[4]Ministry of Health information releases  

[5]Unite against COVID-19 

 

 

show quoted sections

References

Visible links
1. https://www.health.govt.nz/our-work/dise...
2. http://scanmail.trustwave.com/?c=15517&a...
3. mailto:[email address]
4. https://www.health.govt.nz/about-ministr...
5. https://covid19.govt.nz/

Link to this

From: OIA Requests


Attachment image001.jpg
2K Download

Attachment AS Emet Response.pdf
222K Download View as HTML


Kia ora AS Emet

 

 

Please find attached a letter regarding your request for information.

 

We look forward to your response.

 

 

 

Ngā mihi

 

OIA Services Team

[1]www.health.govt.nz

[2]Ministry of Health information releases

[3]Unite against COVID-19

 

 

 

 

show quoted sections

References

Visible links
1. http://www.health.govt.nz/
2. https://www.health.govt.nz/about-ministr...
3. https://covid19.govt.nz/

Link to this

ASE left an annotation ()

Link to this

From: OIA Requests


Attachment image001.jpg
8K Download

Attachment H202116783 ASE FINAL.pdf
257K Download View as HTML


Morena AS Emet

 

Please find attached a response to your requests for official information.

 

Ngā mihi

 

OIA Services

Office of the Director-General | Ministry of Health

 

E: [1][email address]

 

 

show quoted sections

References

Visible links
1. mailto:[email address]

Link to this

ASE left an annotation ()

Complaint filed with Ombudsman.

https://fyi.org.nz/request/17872-consoli...

Link to this

Things to do with this request

Anyone:
Ministry of Health only: